Sumoylated HSP90 is a dominantly inherited plasma cell dyscrasias risk factor

Journal of Clinical Investigation

Volumn 125, Issue 1, 2015, Pages 316-323

  Preuss, Klaus Dieter ^a   Pfreundschuh, Michael ^a   Fadle, Natalie ^a   Regitz, Evi ^a   Kubuschok, Boris ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 90; PEPTIDASE; SUMO 1 PROTEIN; SUMO SPECIFIC PROTEASE 2; SUMOYLATED HEAT SHOCK PROTEIN 90 BETA; UNCLASSIFIED DRUG; SUMO1 PROTEIN, HUMAN;

AFRICAN AMERICAN; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; DISEASE ASSOCIATION; EUROPEAN; HETEROZYGOTE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VITRO STUDY; JAPANESE (PEOPLE); MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; NUCLEOTIDE SEQUENCE; PATHOGENESIS; SUMOYLATION; WALDENSTROEM MACROGLOBULINEMIA; ADULT; AGED; CASE CONTROL STUDY; DOMINANT GENE; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; PARAPROTEINEMIA; PEDIGREE; RISK FACTOR;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GENES, DOMINANT; HETEROZYGOTE; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MALE; MIDDLE AGED; PARAPROTEINEMIAS; PEDIGREE; RISK FACTORS; SUMO-1 PROTEIN; SUMOYLATION;

EID: 84920402238     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI76802     Document Type: Article

References (29)

1. Preuss KD, et al. A frequent target of paraproteins in the sera of patients with multiple myeloma and MGUS. Int J Cancer. 2009;125(3):656-661.
2. Grass S, et al. Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobu-linemia. Blood. 2011;117(10):2918-2923.
3. Zwick C, et al. Over one-third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal dominantly inherited risk factor for MGUS/MM. Int J Cancer. 2014;135(4):934-938.
4. Grass S, et al. Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study. Lancet Oncol. 2009;10(10):950-956.
5. Preuss KD, et al. Hyperphosphorylation of auto-antigenic targets of paraproteins is due to inacti-vation of PP2A. Blood. 2011;118(12):3340-3346.
6. Grass S, et al. Paraproteins of familial MGUS/multiple myeloma target family-typical antigens: hyperphosphorylation of autoantigens is a consistent finding in familial and sporadic MGUS/MM. Blood. 2011;118(3):635-637.
7. Pruijn GJ, Wiik A, van Venrooij WJ. The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis. Arthritis Res Ther. 2010;12(1):203.
8. Quarles RH. Myelin-associated glycoprotein (MAG): past, present and beyond. J Neurochem. 2007;100(6):1431-1448.
9. Barton DE, Arquint M, Roder J, Dunn R, Francke U. The myelin-associated glycoprotein gene: mapping to human chromosome 19 and mouse chromosome 7 and expression in quivering mice. Genomics. 1987;1(2):107-112.
10. Lanemo Myhrinder A, et al. A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood. 2008;111(7):3838-3848.
11. Pinder JB, Attwood KM, Dellaire G. Reading, writing, and repair: the role of ubiquitin and the ubiquitin-like proteins in DNA damage signaling and repair. Front Genet. 2013;4:45.
12. Bologna S, Ferrari S. It takes two to tango: Ubiq-uitin and SUMO in the DNA damage response. Front Genet. 2013;4:106.
13. Al-Hakim A, et al. The ubiquitous role of ubiq-uitin in the DNA damage response. DNA Repair (Amst). 2010;9(12):1229-1240.
14. Matunis MJ, Coutavas E, Blobel G. A novel ubiq-uitin-like modification modulates the partitioning of the Ran-GTPase-activating protein Ran-GAP1 between the cytosol and the nuclear pore complex. J Cell Biol. 1996;135(6 pt 1):1457-1470.
15. Mahajan R, Delphin C, Guan T, Gerace L, Melchior F. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell. 1997;88(1):97-107.
16. Janka C, Selmi C, Gershwin ME, Will H, Sternsdorf T. Small ubiquitin-related modifiers: a novel and independent class of autoantigens in primary biliary cirrhosis. Hepatology. 2005;41(3):609-616.
17. Cunningham CN, Krukenberg KA, Agard DA. Intra-and intermonomer interactions are required to synergistically facilitate ATP hydrolysis in Hsp90. J Biol Chem. 2008;283(30):21170-21178.
18. Mollapour M, Neckers L. Post-translational modifications of Hsp90 and their contributions to chaperone regulation. Biochim Biophys Acta. 2012;1823(3):648-655.
19. Pountney DL, Raftery MJ, Chegini F, Blumbergs PC, Gai WP. NSF, Unc-18-1, dynamin-1 and HSP90 are inclusion body components in neuronal intranuclear inclusion disease identified by anti-SUMO-1-immunocapture. Acta Neuropathol. 2008;116(6):603-614.
20. Mollapour M, et al. Asymmetric Hsp90 N domain SUMOylation recruits Aha1 ATP-competitive inhibitors. Mol Cell. 2014;53(2):317-329.
21. Gareau JR, Lima CD. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat Rev Mol Cell Biol. 2010;11(12):861-871.
22. Geiss-Friedlander R, Melchior F. Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol. 2007;8(12):947-956.
23. Greenberg AJ, Rajkumar SV, Vachon CM. Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics. Blood. 2012;119(23):5359-5366.
24. Mencía M, de Lorenzo V. Functional transplantation of the sumoylation machinery into Escherich-ia coli. Protein Expr Purif. 2004;37(2):409-418.
25. Schwamborn K, et al. SUMO assay with peptide arrays on solid support: insights into SUMO target sites. J Biochem. 2008;144(1):39-49.
26. Preuss KD, Fadle N, Regitz E, Held G, Pfreund-schuh M. Inactivation of protein-phosphatase 2A causing hyperphosphorylation of autoantigenic paraprotein targets in MGUS/MM is due to an exchange of its regulatory subunits. Int J Cancer. 2014;135(9):2046-2053.
27. van Dongen JJ, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphop-roliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17(12):2257-2317.
28. Neumann F, et al. Identification of an epit-ope derived from the cancer testis antigen HOM-TES-14/SCP1 presented by dendritic cells to circulating CD4+ T cells. Blood. 2005;106(9):3105-3113.
29. Altman DG. Practical Statistics For Medical Research. Chapman & Hall/CRC Texts in Statistical Science (Book 12). London, United Kingdom: Chapman and Hall; 1990.